SCHEMBL21117065

SCHEMBL21117065

c1ccc(-c2cccc3c2oc2cc(-c4nc(-c5ccc6c(c5)oc5ccccc56)nc(-c5ccc6c(c5)oc5ccccc56)n4)ccc23)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.55
PRKDC P78527 4/20 0.48
GGPS1 O95749 1/20 0.44
MAPT P10636 6/20 0.41
PTGES2 Q9H7Z7 1/20 0.41
AHR P35869 1/20 0.41
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 2/20 0.40
POLB P06746 1/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
HPGD P15428 2/20 0.40
PIK3CD O00329 2/20 0.39
PIK3CB P42338 2/20 0.39
MMP12 P39900 1/20 0.39
MMP13 P45452 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
PIK3CA P42336 1/20 0.38
PIK3CG P48736 1/20 0.38
HCRTR1 O43613 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25627305 0.99 ALOX5 (0.53) ALOX5PRKDCGGPS1MAPTPTGES2
SCHEMBL23228083 0.99 ALOX5 (0.53) ALOX5PRKDCGGPS1MAPTPTGES2
SCHEMBL25646006 0.99 ALOX5 (0.53) ALOX5PRKDCGGPS1MAPTPTGES2
SCHEMBL23913801 0.99 ALOX5 (0.53) ALOX5PRKDCGGPS1MAPTPTGES2
SCHEMBL23913219 0.97 ALOX5 (0.52) ALOX5PRKDCGGPS1MAPTPTGES2
SCHEMBL23228084 0.97 ALOX5 (0.52) ALOX5PRKDCGGPS1MAPTPTGES2
SCHEMBL25645792 0.97 ALOX5 (0.52) ALOX5PRKDCGGPS1MAPTPTGES2
SCHEMBL24215962 0.97 ALOX5 (0.52) ALOX5PRKDCGGPS1MAPTPTGES2
SCHEMBL23913218 0.97 ALOX5 (0.56) ALOX5PRKDCGGPS1MAPTPTGES2
SCHEMBL25645605 0.97 ALOX5 (0.52) ALOX5PRKDCGGPS1MAPTPTGES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190198780-A1 ORGANIC COMPOUND AND COMPOSITION AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190198780-A1 ORGANIC COMPOUND AND COMPOSITION AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE OR10J3, OXER1, OR51E2 ALOX5 1427/4885PRKDC 3582/4885GGPS1 2855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.